脑卒中后日间嗜睡的机制及治疗研究进展

赵 颖玲1, 廖 书田1, 吴 亭燕1, 蓝 娇娜2
1、右江民族医学院研究生学院;右江民族医学院附属医院康复医学科
2、右江民族医学院附属医院康复医学科

摘要


日间嗜睡（EDS）是脑卒中后普遍存在的睡眠障碍之一。研究表明，EDS降低脑卒中患者的生活质量，影
响认知功能，对脑卒中康复和预后有不利影响，应尽早针对脑卒中患者EDS开展康复治疗，但在临床上相较于其他
脑卒中并发症，EDS并没有引起足够重视。本研究对脑卒中后EDS的发病机制及康复治疗研究现状进行综述，以期
早日诊治EDS的同时，改善脑卒中预后。

关键词


日间嗜睡;脑卒中;机制;康复治疗

全文:

PDF


参考


[1]于逢春，张晨.卒中相关睡眠障碍评估与管理中国专家共识2023.中国卒中杂志.2023；18（2）：221-239.

[2]王文熠，陈光.脑卒中后继发昼间嗜睡的影响因素与治疗及其对预后的影响研究进展.中国全科医学.2021；24（12）：1570-1574.

[3]Facchin L, Schöne C, Möck M, et al. Slow waves promote sleep-dependent plasticity and functional recovery after stroke. J Neurosci. 2020;40(45):8637-8651.

[4]Sharma R, Sahota P, Sahota K. Ischemic stroke disrupts sleep homeostasis in middle-aged mice. Cells. 2022;11(18):2890. doi:10.3390/cells11182890

[5]Chu TT, Sun C, Zheng YH, et al. Study on the mechanisms of ischemic stroke impacting sleep homeostasis and circadian rhythms in rats. CNS Neurosci Ther. 2025;31(2):e70153. doi:10.1111/cns.70153

[6]Wu W, Li J, Wu Y, et al. Sleep and cognitive abnormalities in acute minor thalamic infarction. Neurosci Bull. 2016;32(4):341-348. doi:10.1007/s12264-016-0043-5

[7]Pradeep R, Sivanandapanicker JJ, Menon RN, et al. Wake-up sleepyhead: unilateral diencephalic stroke presenting with excessive sleepiness. J Neurosci Rural Pract. 2019;10(1):145-147.

[8]王文熠，陈光.脑卒中后昼间嗜睡与患者睡眠呼吸障碍的相关性研究.天津医药.2023；51（12）：1369-1373.

[9]Mediano O, Barceló A, de la Peña M, et al. Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J. 2007;30(1):110-113.

[10]Veasey SC, Davis CW, Fenik P, et al. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep. 2004;27(2):194-201.

[11]Zhu Y, Fenik P, Zhan G, et al. Selective loss of catecholaminergic wake-active neurons in a murine sleep apnea model. J Neurosci. 2007;27(37):10060-10071.

[12]张伟，汪雅茹，邹志伟.卒中后失眠病因、发病机制及治疗方法的研究进展.山东医药.2025；65（11）： 118-121，126.

[13]刘慧勤，张桂青，王惠惠，等.脑卒中后睡眠障碍患者血清NSE、IL-1β及5-HT水平的变化及意义.中国实用神经疾病杂志.2021；24（8）：714-718.

[14]陈少元.急性缺血性脑卒中初始hs-CRP、Hcy、 PCT水平与卒中后日间过度嗜睡的相关性研究.中国实验诊断学.2025；29（8）：874-879.

[15]Hoch CR, Klinedinst NJ. Excessive daytime sleepiness, inflammation, and platelet energy metabolism in chronic stroke survivors. Nurs Res. 2025;74(1):79-84.

[16]Sampsonas F, Kallianos A, Kallianos A, et al. Poststroke sleep disordered breathing and the effect of positive airway pressure treatment: an updated systematic review and meta-analysis of randomized control trials. Sleep Med Rev. 2025;85:102207.

[17]Suusgaard J, Lechner K, Knudsen UB, et al. Sleepiness, fatigue, and obstructive sleep apnea in stroke patients. J Stroke Cerebrovasc Dis. 2025;34(8):108056. doi:10.1016/j.jstrokecerebrovascdis.2025.108056

[18]Kim DY, Lee E, Jang W, et al. Improvement of cognitive function after continuous positive airway pressure treatment for subacute stroke patients with obstructive sleep apnea: a randomized controlled trial. Brain Sci. 2019;9(10):252. doi:10.3390/brainsci9100252

[19]韩海燕，任寿安.阻塞性睡眠呼吸暂停低通气综合征合并急性缺血性脑卒中患者持续正压通气治疗的临床观察.中国实用医药.2012；7（16）：63-65.

[20]王文熠，王锋.醒脑开窍针刺法结合灵龟八法治疗脑卒中后昼间嗜睡.吉林中医药.2015；35（11）： 1176-1179.

[21]赵小红.灵龟八法结合醒脑开窍针刺对卒中后昼间嗜睡患者的临床疗效及对睡眠结构影响的随机对照研究[学位论文].天津：天津中医药大学；2024. doi： 10.27368/d.cnki.gtzyy.2024.000191

[22]蒋燕春.升阳通督调神针法联合电针治疗缺血性脑卒中后失眠的临床研究[学位论文].昆明：云南中医药大学；2025. doi：10.27460/d.cnki.gyzyc.2025.000071

[23]李春雨，金龙涛，马玉琴，等.心脑共治针法治疗缺血性脑卒中睡眠节律障碍的临床研究.中医药信息 .2022；39（1）：60-64. doi：10.19656/j.cnki.1002- 2406.20220112

[24]Kim WH, Jang BH, Kim JM, et al. The effect of bright light therapy on sleep and quality of life in patients with poststroke insomnia. Psychosom Med. 2021;84(1):123-130.

[25]Lopes JP. Efeitos da terapia com luz no humor e nas alterações do ritmo vigília-sono em paciente com acidente vascular cerebral isquêmico [dissertation]. São Paulo: [University name]; 2017.

[26]Soreca I, Arnold N, Dombrovski AY. Bright light therapy for CPAP-resistant OSA symptoms. J Clin Sleep Med. 2024;20(2):211-219.

[27]Lal C, Weaver TE, Bae CJ, et al. Excessive daytime sleepiness in obstructive sleep apnea: mechanisms and clinical management. Ann Am Thorac Soc. 2021;18(5):757-768.

[28]Cuomo MC, Sheehan AH, Jordan JK. Solriamfetol for the management of excessive daytime sleepiness. J Pharm Pract. 2022;35(6):963-970.

[29]Hoy SM. Solriamfetol: a review in excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnoea. CNS Drugs. 2023;37(11):1009-1020.

[30]Dauvilliers Y, Bassetti C, Lammers GJ, et al. Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment: a randomized trial. Am J Respir Crit Care Med. 2020;201(9):1135-1145.

[31]Nirogi R, Shanmuganathan D, Jayarajan P, et al. Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation. Psychopharmacology. 2021;238(6):1495-1511.

[32]Nirogi R, Shanmuganathan D, Jayarajan P, et al. Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. Sleep Med. 2024;124:618-626.


Refbacks

  • 当前没有refback。